Article ID Journal Published Year Pages File Type
4228378 European Journal of Radiology 2007 4 Pages PDF
Abstract
With the use of iodixanol in intermediate-risk patients, 3% of the patients develop CIN on day 3 without need for a specific therapy or persistence on day 7.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Radiology and Imaging
Preview
Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography
Authors
, , , , ,